The platform functions as an interface atop DeepIntent’s existing healthcare marketing cloud, Helix. By integrating patient and provider data, the tool enables users to identify market trends, segment audiences, and forecast campaign performance without requiring manual data processing. For agencies, the shift is significant: beta testing showed a 50% improvement in planning cycle times, allowing strategists to pivot from static reports to dynamic, real-time campaign optimization.
DeepIntent CEO Chris Paquette described the technology as a democratization of critical insights, noting that the ability to bridge the gap between media data and clinical outcomes is essential for modern therapeutic product launches. Beyond internal analytics, the system supports activation across the company's demand-side platform and external social channels. Havas Media Network and Fingerpaint Marketing are among the early adopters, citing the platform's capacity to handle granular, HIPAA-compliant analysis that was previously considered unfeasible at such speed.





Comments (0)
No comments yet. Be the first!